Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase - increased expression with reduced muscle damage

被引:195
作者
McMahon, JM
Signori, E
Wells, KE
Fazio, VM
Wells, DJ
机构
[1] Charing Cross Hosp, Imperial Coll Sch Med, Dept Neuromuscular Dis, Div Neurosci & Psychol Med,Gene Targeting Unit, London W6 8RP, England
[2] CNR, Inst Neurobiol & Mol Med, Rome, Italy
[3] IRCCS H Casa Sollievo Sofferenza, Lab Mol Pathol & Gene Therapy, San Giovanni Rotondo, FG, Italy
[4] Sch Med, Lab Mol Med & Biotechnol, Rome, Italy
基金
英国惠康基金;
关键词
muscular dystrophy; gene therapy; plasmid; skeletal muscle; electroporation; fibres;
D O I
10.1038/sj.gt.3301522
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The efficiency of plasmid gene transfer to skeletal muscle can be significantly improved by the application of an electrical field to the muscle following injection of plasmid DNA. However, this electrotransfer is associated with significant muscle damage which may result in substantial loss of transfected muscle fibres. Reduction of the voltage used in the technique can result in a decrease in muscle damage, with a concomitant reduction in expression, but without a significant decrease in the number of transfected fibres. Pre-treatment of the muscle with a solution of bovine hyaluronidase greatly increases the efficiency of plasmid gene transfer when used in conjunction with electrotransfer, but not when used alone. This combination treatment results in greatly enhanced levels of transfected muscle fibres without the increases in muscle damage associated with the electrotransfer process.
引用
收藏
页码:1264 / 1270
页数:7
相关论文
共 52 条
[31]   CANCER GENE-THERAPY USING PLASMID DNA - PHARMACOKINETIC STUDY OF DNA FOLLOWING INJECTION IN MICE [J].
LEW, D ;
PARKER, SE ;
LATIMER, T ;
ABAI, AM ;
KUWAHARARUNDELL, A ;
DOH, SG ;
YANG, ZY ;
LAFACE, D ;
GROMKOWSKI, SH ;
NABEL, GJ ;
MANTHORPE, M ;
NORMAN, J .
HUMAN GENE THERAPY, 1995, 6 (05) :553-564
[32]   The role of cell surface receptors in the activation of human B cells by phosphorothioate oligonucleotides [J].
Liang, H ;
Reich, CF ;
Pisetsky, DS ;
Lipsky, PE .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1438-1445
[33]  
Macfarlane DE, 1998, J IMMUNOL, V160, P1122
[34]   3-AMINOPROPYLTRIETHOXYSILANE (APES) - A NEW ADVANCE IN SECTION ADHESION [J].
MADDOX, PH ;
JENKINS, D .
JOURNAL OF CLINICAL PATHOLOGY, 1987, 40 (10) :1256-1257
[35]   Efficient lipid-mediated gene transfer to articular chondrocytes [J].
Madry, H ;
Trippel, SB .
GENE THERAPY, 2000, 7 (04) :286-291
[36]   GENE-THERAPY BY INTRAMUSCULAR INJECTION OF PLASMID DNA - STUDIES ON FIREFLY LUCIFERASE GENE-EXPRESSION IN MICE [J].
MANTHORPE, M ;
CORNEFERTJENSEN, F ;
HARTIKKA, J ;
FELGNER, J ;
RUNDELL, A ;
MARGALITH, M ;
DWARKI, V .
HUMAN GENE THERAPY, 1993, 4 (04) :419-431
[37]   Electropermeabilization of skeletal muscle enhances gene transfer in vivo [J].
Mathiesen, I .
GENE THERAPY, 1999, 6 (04) :508-514
[38]  
MAULE JG, 1999, THESIS U LONDON
[39]   Inflammatory responses following direct injection of plasmid DNA into skeletal muscle [J].
McMahon, JM ;
Wells, KE ;
Bamfo, JE ;
Cartwright, MA ;
Wells, DJ .
GENE THERAPY, 1998, 5 (09) :1283-1290
[40]   Analysis of plasmid DNA from a pharmaceutical perspective [J].
Middaugh, CR ;
Evans, RK ;
Montgomery, DL ;
Casimiro, DR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (02) :130-146